A new selective vascular endothelial growth factor receptor 2 inhibitor ablates disease in a mouse model of psoriasis

Author：          

Publisher： Spandidos Publications

ISSN： 1791-2997

Source： Molecular Medicine Reports, Vol.8, Iss.2, 2013-01, pp. : 434-438

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

γ-secretase inhibitor up-regulates vascular endothelial growth factor receptor-2 and endothelial nitric oxide synthase

By            

Experimental and Therapeutic Medicine, Vol. 2, Iss. 4, 2011-01 ,pp. : 725-729

Spandidos Publications

Access to resources Recommend Favorite

Effects of combination anti-vascular endothelial growth factor receptor and anti-epidermal growth factor receptor therapies on the growth of gastric cancer in a nude mouse model

By Jung Y.D.   Mansfield P.F.   Akagi M.   Takeda A.   Liu W.   Bucana C.D.   Hicklin D.J.   Ellis L.M.  

European Journal of Cancer, Vol. 38, Iss. 8, 2002-05 ,pp. : 1133-1140

Elsevier

Access to resources Recommend Favorite

Selective Blockade of Vascular Endothelial Growth Factor Receptor 2 With an Antibody Against Tumor-Derived Vascular Endothelial Growth Factor Controls the Growth of Human Pancreatic Adenocarcinoma Xenografts

By Holloway Shane   Beck Adam   Shivakumar Latha   Shih Jessica   Fleming Jason   Brekken Rolf  

Annals of Surgical Oncology, Vol. 13, Iss. 8, 2006-08 ,pp. : 1145-1155

Springer Publishing Company

Access to resources Recommend Favorite

Biomarkers for assessment of pharmacologic activity for a vascular endothelial growth factor (VEGF) receptor inhibitor, PTK787/ZK 222584 (PTK/ZK): translation of biological activity in a mouse melanoma metastasis model to phase I studies in patients with advanced colorectal cancer with liver metastases

By Lee Lucy   Sharma Sunil   Morgan Bruno   Allegrini Peter   Schnell Christian   Brueggen Josef   Cozens Robert   Horsfield Mark   Guenther Clemens   Steward Will   Drevs Joachim   Lebwohl David   Wood Jeanette   McSheehy Paul  

Cancer Chemotherapy and Pharmacology, Vol. 57, Iss. 6, 2006-06 ,pp. : 761-771

Springer Publishing Company

Access to resources Recommend Favorite

Characterization of the expression and clinical features of epidermal growth factor receptor and vascular endothelial growth factor receptor2 in esophageal carcinoma

By            

Oncology Letters, Vol. 10, Iss. 6, 2015-01 ,pp. : 3696-3704

Spandidos Publications

Access to resources Recommend Favorite